| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-16,717 | -16,984 | -18,613 | -12,688 | -12,700 |
|
Research and Development Expenses
|
-67,887 | -66,267 | -51,964 | -30,312 | -27,080 |
|
Operating Income/Expenses
|
-84,604 | -83,251 | -70,577 | -43,000 | -39,780 |
|
Total Operating Profit/Loss
|
-84,604 | -83,251 | -70,577 | -43,000 | -39,780 |
| Net Investment Income
|
-17,489 | 33,449 | 30,900 | -76,211 | 0 |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | -48,648 |
|
Other Income/Expense, Non-Operating
|
3,567 | 4,220 | 3,924 | 2,674 | 462 |
|
Non-Operating Income/Expenses, Total
|
-13,922 | 37,669 | 34,824 | -73,537 | -48,186 |
|
Pretax Income
|
-98,526 | -45,582 | -35,753 | -116,537 | -87,966 |
|
Provision for Income Tax
|
-35 | -35 | -431 | 0 | 0 |
|
Net Income from Continuing Operations
|
-98,561 | -45,617 | -36,184 | -116,537 | -87,966 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-98,561 | -45,617 | -36,184 | -116,537 | -87,966 |
|
Net Income after Non-Controlling/Minority Interests
|
-98,561 | -45,617 | -36,184 | -116,537 | -87,966 |
| Preferred/Other Stock Distribution
|
3,440 | -- | -- | -- | -- |
|
Other Adjustments to Net Income Available to Common Stockholders
|
1,329 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
-96,470 | -45,617 | -36,184 | -116,537 | -87,966 |
|
Dilution to Earnings
|
0 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
-96,470 | -45,617 | -36,184 | -116,537 | -87,966 |
| Basic EPS
|
-0.90 | -0.52 | -0.66 | -3.74 | -6.16 |
| Diluted EPS
|
-0.90 | -0.52 | -0.66 | -3.74 | -6.16 |
|
Basic Weighted Average Shares Outstanding
|
99,781.2600 | 81,836.2460 | 48,543.7870 | 24,619.1970 | 14,285.2540 |
|
Diluted Weighted Average Shares Outstanding
|
99,781.2600 | 81,836.2460 | 48,543.7870 | 24,619.1970 | 14,285.2540 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-98,526 | -45,582 | -35,753 | -116,537 | -87,966 |
|
EBITDA
|
-98,526 | -45,269 | -35,394 | -116,163 | -87,593 |
|
Normalized EBITDA
|
-70,788 | -68,267 | -53,172 | -33,407 | -30,792 |
|
Normalized Income
|
-70,823 | -63,785.4200 | -50,228.6200 | -33,781 | -31,165 |
|
Total Unusual Items
|
27,738 | -22,998 | -17,778 | 82,756 | 56,801 |
|
Total Unusual Items Excluding Goodwill
|
27,738 | -22,998 | -17,778 | 82,756 | 8,153 |
12/31/2022 - 9/17/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade